Vardenafil 20 Mg

Other > vardenafil oral


crofelemercrofelemer increases levels of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Access options

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors chloramphenicolchloramphenicol will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors chloramphenicol will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors cimetidinecimetidine will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. cimetidine will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ECG monitoring is recommended, along with drugs that may prolong the QT interval. Crofelemer has the potential to

Product Dosage Quantity + Bonus Price
Levitra Soft Tabs20mg180 + 10 Pills398.14€ 379.18€
Kamagra Gold50 mg12 Pills47.30€ 45.05€
Kamagra Soft Tabs100mg12 Pills57.55€ 54.81€
Cialis Generic60mg10 Pills41.22€ 39.26€
Levitra Professional20mg270 + 6 Pills738.98€ 703.79€
Viagra Generic25mg360 + 10 Pills213.68€ 203.50€
Priligy Generic Dapoxetine60mg20 + 4 Pills77.31€ 73.63€
Viagra Professional100mg30 Pills88.92€ 84.69€
Kamagra 100 mg100 mg360 + 6 Pills839.95€ 799.95€
Apcalis SX Oral Jelly20mg10 Sachets58.75€ 55.95€
Viagra Generic200mg270 + 10 Pills379.76€ 361.68€

inhibit CYP3A4 at concentrations expected

Other uses for this medicine

St John's WortSt John's Wort will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. St John's Wort will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. terazosinvardenafil increases effects of terazosin by pharmacodynamic synergism. vardenafil increases effects of terazosin by pharmacodynamic synergism. tetrabenazinetetrabenazine and vardenafil both increase QTc interval.

Authors and Affiliations

tetrabenazine and vardenafil both increase QTc interval. tovorafenibtovorafenib will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid coadministration of tovorafenib (a weak CYP3A4 inducer) with CYP3A substrates where minimal concentration changes may lead to serious therapeutic failures. If unavoidable, monitor patients for loss of efficacy unless otherwise recommended in the CYP3A4 substrate prescribing information. tovorafenib will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Pulmonary Arterial Hypertension (Orphan)

tucatinibtucatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid concomitant use of tucatinib with CYP3A substrates, where minimal concentration changes may lead to serious or life-threatening toxicities. If unavoidable, reduce CYP3A substrate dose according to product labeling. tucatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Exercise extreme caution when vilanterol coadministered with drugs that prolong QTc interval; adrenergic agonist effects on the cardiovascular system may be potentiated. in the gut; unlikely to

  • Vardenafil enhances blood flow to the penis.
  • It is sold under brand names like Levitra and Staxyn.
  • The drug is generally well-tolerated when used correctly.
  • Common side effects include dizziness and nasal congestion.
  • It should be stored in a cool, dry place away from children.
  • Vardenafil is not an aphrodisiac; it requires sexual stimulation.
  • Excessive doses can increase cardiovascular risks.
  • It’s important to follow the doctor’s instructions for use.
  • Patients with heart conditions should consult a doctor before use.
  • Vardenafil may cause visual disturbances in some people.
  • Regular medical review is recommended during treatment.

inhibit systemically because minimally absorbed.

  • Vardenafil is sometimes used off-label for other circulatory issues.
  • It is important to avoid using if you have a history of stroke.
  • Consult your healthcare provider if you experience chest pain.
  • Patients with ocular conditions should use caution.
  • Vardenafil may cause a drop in blood pressure.
  • The medication should be stored away from heat and moisture.
  • It is safer to take Vardenafil under medical supervision.
  • Lifelong medical monitoring may be required in some cases.
  • Vardenafil is not suitable for men with certain heart conditions.
  • Combining with nitrates can cause dangerous hypotension.
  • Always read the medication guide before use.

Vardenafil dose may need to be reduced

Side Effect Frequency Severity Management
Headache Common Mild Over-the-counter analgesics
Flushing Common Mild Cooling measures
Nasal congestion Less common Mild Symptomatic relief
Dizziness Less common Mild Avoid driving or operating heavy machinery

if coadministered with moderate

Rights and permissions

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors cortisonecortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. cortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. crizotinibcrizotinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Dose reduction may be needed for coadministered drugs that are predominantly metabolized by CYP3A. crizotinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. or strong CYP3A4 inhibitors.

Consult a Licensed Doctor Online About Generic Levitra (Vardenafil)

vardenafil increases toxicity of umeclidinium bromide/vilanterol inhaled by QTc interval. Concomitant use of vemurafenib with drugs that prolong QT interval is not recommended. vilanterol/fluticasone furoate inhaledvardenafil increases toxicity of vilanterol/fluticasone furoate inhaled by QTc interval. vardenafil increases toxicity of vilanterol/fluticasone furoate inhaled by QTc interval. Avoid coadministration of ziftomenib with other drugs known to prolong the QTc interval.

Brand Names:

If unavoidable, obtain ECGs when initiating, during concomitant use, and as clinically indicated. Interrupt ziftomenib with QTc interval > 500 ms or a change from baseline is > 60 ms vardenafil and ziftomenib both erectile dysfunction tablets uk increase QTc interval. Interrupt ziftomenib with QTc interval > 500 ms or a change from baseline is > 60 ms zotepinevardenafil increases effects of zotepine by pharmacodynamic synergism. vardenafil increases effects of zotepine by pharmacodynamic synergism. adagrasibadagrasib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

2.1 Active Ingredient and Mechanism of Action

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors adagrasib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors alfuzosinvardenafil and alfuzosin both increase QTc interval. Use Caution/Monitor.alfuzosin and vardenafil both increase QTc interval. vardenafil and alfuzosin both increase QTc interval. Monitor blood pressure response to phosphodiesterase type 5 (PDE5) inhibitors in patients receiving concurrent blood pressure lowering therapy. crofelemer increases levels of vardenafil

Product Overview

clarithromycinclarithromycin will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Limit vardenafil dose to 2.5 mg/24 hr clozapineclozapine and vardenafil both increase QTc interval. clozapine and vardenafil both increase QTc interval. cobicistatcobicistat will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors conivaptan will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

503A vs 503B

amiodaroneamiodarone will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors amiodarone will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors apomorphineapomorphine and vardenafil both increase QTc interval. apomorphine and vardenafil both increase QTc interval. aprepitantaprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Pregnancy and breastfeeding

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors aprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors aripiprazolearipiprazole and vardenafil both increase QTc interval. aripiprazole and vardenafil both increase QTc interval. armodafinilarmodafinil will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. armodafinil will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Before Using This Medicine:

artemether/lumefantrineartemether/lumefantrine will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. artemether/lumefantrine will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. asenapinevardenafil increases effects of asenapine by pharmacodynamic synergism. vardenafil increases effects of asenapine by pharmacodynamic synergism. atazanaviratazanavir will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. cyclosporinecyclosporine will increase the level or effect

  • Vardenafil dosage adjustments may be needed for older adults.
  • It may pose risks in men with low blood pressure.
  • Always adhere to the prescribed therapeutic regimen.
  • It is not recommended to exceed 20 mg per dose.
  • Vardenafil is not intended for use with other ED medications.
  • Precise timing of doses ensures efficacy and safety.
  • The drug may improve sexual confidence and satisfaction.
  • Side effects are usually temporary and dose-related.
  • Alcohol and high-fat foods can delay onset of action.
  • Avoid using Vardenafil if allergies to it are known.
  • Proper hydration can enhance its effectiveness.

of vardenafil by affecting

Form Strengths Notes
Vardenafil tablets 10 mg, 20 mg Most common doses
Orally disintegrating tablets 10 mg, 20 mg Alternative for easier administration
Liquid suspension Not widely available Under research or off-label use

hepatic/intestinal enzyme CYP3A4 metabolism.

Adverse reactions

Limit vardenafil dose to 2.5 mg/24 hr atomoxetineatomoxetine and vardenafil both increase QTc interval. atomoxetine and vardenafil both increase QTc interval. bedaquilinevardenafil and bedaquiline both increase QTc interval. vardenafil and bedaquiline both increase QTc interval. Either increases effects of the other by Mechanism: pharmacodynamic synergism.

Uses of This Medicine:

bicalutamidebicalutamide will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors bicalutamide will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors bosentanbosentan will decrease the lovegra women level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. bosentan will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. budesonidebudesonide will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Lifestyle Adjustments for Enhanced Performance:

budesonide will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. butalbitalbutalbital will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. butalbital will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ceritinibceritinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors ceritinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.